In this Exclusive Interview, Joshua Safer talks with Diabetes in Control publisher Steve Freed during the AACE 2018 convention in Boston about transgender medicine and the approach to transgender care.

In part 1 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about the need to understand the evidence for and approach to transgender medicine, and strategies for the use of hormones.

In part 2 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about working with transgender patients and the course of a conversation with a new patient.

In part 3 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about the number of specialists that can be found and more on the field overall as a specialty.

In part 4 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about the potential of hormones to cause diabetes.

Lower composite incidence of macrovascular events, lower incidence of coronary artery disease at 5 years

Both preserved β-cell function in obese adults with impaired glucose tolerance, mild T2DM

Even greater risk for mortality, CV events in presence of several high-variability metabolic parameters

Discontinuation of insulin, other diabetes medications seen in case series of three patients

If you have ever had to deliver the message to the parent of a newly diagnosed type 1 patient, you likely have had to explain why we don’t manage to perfection from day 1. Sometimes these adults can not grasp the concept of a honeymoon period where the pancreas starts …